Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$130.05-0.8%$125.14$96.06▼$133.55$274.72B0.641.51 million shs2.28 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis0.00%-1.78%+4.78%+7.42%+11.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$130.05-0.8%$125.14$96.06▼$133.55$274.72B0.641.51 million shs2.28 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis0.00%-1.78%+4.78%+7.42%+11.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVSNovartis 2.10Hold$120.33-7.47% DownsideCurrent Analyst Ratings BreakdownLatest NVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025NVSNovartisWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)9/27/2025NVSNovartisWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)9/12/2025NVSNovartisThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Sell$119.00 ➝ $118.008/21/2025NVSNovartisDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025NVSNovartisMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$123.00(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVSNovartis$55.19B4.98$10.70 per share12.15$21.59 per share6.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVSNovartis$11.94B$6.8718.9314.761.8025.64%41.08%16.83%10/28/2025 (Estimated)Latest NVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/28/2025Q3 2025NVSNovartis$2.28N/AN/AN/A$13.70 billionN/A7/17/2025Q2 2025NVSNovartis$2.38$2.42+$0.04$2.06$13.94 billion$14.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVSNovartis$2.591.99%N/A37.70%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVSNovartis0.530.820.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVSNovartis13.12%Insider OwnershipCompanyInsider OwnershipNVSNovartis0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVSNovartis75,8832.11 billion2.11 billionOptionableNVS HeadlinesRecent News About These CompaniesVanguard Personalized Indexing Management LLC Purchases 16,063 Shares of Novartis AG $NVSOctober 12 at 5:46 AM | marketbeat.comBlair William & Co. IL Sells 10,415 Shares of Novartis AG $NVSOctober 12 at 4:00 AM | marketbeat.comNovartis AG $NVS Shares Sold by Mengis Capital Management Inc.October 11 at 6:38 AM | marketbeat.comBaldwin Wealth Partners LLC MA Has $4.56 Million Stake in Novartis AG $NVSOctober 11 at 5:24 AM | marketbeat.comNovartis AG $NVS Stake Lowered by US Bancorp DEOctober 11 at 4:14 AM | marketbeat.comNovartis (NYSE:NVS) Upgraded at Wall Street ZenOctober 11 at 2:05 AM | marketbeat.comNovartis (NYSE:NVS) Given "Buy (B)" Rating at Weiss RatingsOctober 10 at 10:04 AM | marketbeat.comAkero: Novartis Acquisition Puts Focus On Unprecedented MASH Data With EFXOctober 10 at 8:06 AM | seekingalpha.comZacks Research Analysts Lift Earnings Estimates for NovartisOctober 10 at 7:44 AM | marketbeat.comLeo Wealth LLC Has $1.98 Million Stock Holdings in Novartis AG $NVSOctober 10 at 6:31 AM | marketbeat.comCallan Family Office LLC Raises Stock Holdings in Novartis AG $NVSOctober 10 at 5:23 AM | marketbeat.comShould You Buy Novartis Stock Before October 28?October 8, 2025 | msn.comNovartis (NYSE:NVS) Sees Strong Trading Volume - Here's WhyOctober 8, 2025 | marketbeat.comHere's Why Novartis (NVS) is a Strong Value StockOctober 8, 2025 | zacks.com3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump DealOctober 8, 2025 | zacks.comSpectrum Asset Management Inc. NB CA Acquires New Position in Novartis AG $NVSOctober 8, 2025 | marketbeat.comNovartis AG $NVS Shares Acquired by DAVENPORT & Co LLCOctober 8, 2025 | marketbeat.comNovartis (NYSE:NVS) Reaches New 1-Year High - Here's What HappenedOctober 7, 2025 | marketbeat.comMerit Financial Group LLC Has $3.69 Million Stake in Novartis AG $NVSOctober 7, 2025 | marketbeat.comNovartis AG $NVS Shares Acquired by Simplicity Wealth LLCOctober 7, 2025 | marketbeat.com3 Reasons Growth Investors Will Love Novartis (NVS)October 6, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVS Company DescriptionsNovartis NYSE:NVS$130.05 -1.01 (-0.77%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$130.76 +0.71 (+0.55%) As of 04:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Microsoft 365 Premium Marks the Next Phase of AI Monetization 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings Bassett Furniture: Buy Now, Sit Back, and Collect Dividends Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
